Nektar Therapeutics stockNKTR
Nektar Therapeutics trades at $36.15, 66.8% below its 52-week high (Apr 20, 2026). The price is below its 50- and 200-day averages, a downtrend. −14.5% year to date, −33.4% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 12, 2026.
Ratings, candles, signals and the screener for NKTR — after you log in
Open the terminalFrequently asked questions about Nektar Therapeutics
What is the Nektar Therapeutics stock price?
At the close on Nov 5, 2026: $36.15 (−6.06% on the day). 52-week high: $109.00 on Apr 20, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Nektar Therapeutics report earnings?
The next quarterly report is on Nov 12, 2026. Last quarter, earnings per share changed +58% year over year, revenue −9%.
Does Nektar Therapeutics pay dividends?
No, Nektar Therapeutics does not pay dividends.
Where does Nektar Therapeutics trade and how to buy it?
Ticker NKTR, exchange Nasdaq, listed since 1994. You can buy it through a broker with access to US exchanges.
Should I buy Nektar Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for NKTR are in the terminal after you log in.